Everest Organics
add_icon

Everest Organics

418.90
+2.50
(0.60%)
Market Cap
₹- Cr
PE Ratio
-
Volume
477.00
Day High - Low
₹418.90 - ₹408.00
52W High-Low
₹477.00 - ₹142.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
- Cr
EPS
-
PB Ratio
-
Book Value
74.67
EBITDA
-
Dividend Yield
- %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
-
Forecast For
Actual

Company News

View All News
Caret
neutral
Everest Organics Limited has issued a postal ballot notice seeking shareholder approval for three special resolutions including appointment of Mr. Venkata Satya Subbarao Pachigolla as Whole-Time Director with Rs. 2,00,000 monthly remuneration and designation changes for two existing directors. The remote e-voting period runs from November 17, 2025 to December 16, 2025, with results to be declared by December 18, 2025.
positive
Everest Organics Limited reported a profit of Rs 59.47 lakhs for the quarter ended September 30, 2025, compared to a loss of Rs 634.96 lakhs in the previous year quarter. Revenue from operations increased to Rs 10,022.53 lakhs from Rs 7,210.48 lakhs year-on-year. For the half-year period, the company posted a profit of Rs 256.10 lakhs versus a loss of Rs 929.03 lakhs in the corresponding previous period. The Board approved the appointment of Venkata Satya Subbarao Pachigolla as Additional Director (Whole-time Director), subject to shareholder approval through postal ballot. The company also announced designation changes for two existing directors - Kirankumar Rampally will move from Non-Executive Non-Independent to Independent Director, while Prasad Venkata Satya Sundara Srikakolapu will change from Independent Director to Non-Executive Non-Independent. The auditor's report highlighted two qualification issues: the company is operating at enhanced production levels without necessary approvals from Telangana State Pollution Control Board, and has not provided for Rs 143 lakhs in interest claimed by suppliers for delayed payments.
neutral
Everest Organics Limited's Board of Directors approved the re-appointment of Dr. Srikakarlapudi Sirisha as Managing Director for three years from August 10, 2025 to August 09, 2028, and Mr. Srikakarlapudi Harikrishna as Whole-time Director for three years from September 25, 2025 to September 24, 2028. Both appointments are subject to shareholder approval at the 32nd Annual General Meeting. The board also appointed Ms. Shweta Singh as Company Secretary and Compliance Officer effective August 05, 2025. Dr. Sirisha, 48, holds M.B.B.S and MD degrees and has been with the company since 2014, also serving as CEO. Mr. Harikrishna, 46, is a mechanical engineer who joined in 2007 and brings expertise in project planning and engineering. Both directors are promoters and related to each other. Ms. Singh is an associate member of the Institute of Company Secretaries of India with over 3 years of compliance experience.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
790.15
-
#1 -
-
-
-
-
34.61
699.20
-
#1 -
-
-
-
-
43.29
64.57
-
#1 -
-
-
-
-
21.03
554.80
-
#1 -
-
-
-
-
37.85
28,850.00
-
#1 -
-
-
-
-
39.24
42.05
-
#1 -
-
-
-
-
41.15
54.60
-
#1 -
-
-
-
-
42.72
5,001.00
-
#1 -
-
-
-
-
43.40
414.10
-
#1 -
-
-
-
-
43.97
26.95
-
#1 -
-
-
-
-
41.68
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
107
100
108
113
156
169
183
202
190
198
160
189
Expenses
98
94
101
105
138
148
159
194
182
186
152
171
EBITDA
8
6
7
8
18
21
24
9
8
12
8
18
Operating Profit %
7 %
6 %
6 %
6 %
11 %
12 %
13 %
3 %
1 %
6 %
5 %
9 %
Depreciation
3
3
2
3
3
3
3
4
5
6
6
6
Interest
3
3
3
3
3
3
3
3
3
6
5
5
Profit Before Tax
2
0
2
2
12
14
17
2
0
1
-3
7
Tax
0
0
0
1
5
3
4
1
0
1
-2
1
Net Profit
2
0
1
2
8
11
14
1
-0
0
-1
7
EPS in ₹
1.78
0.54
1.69
2.14
9.39
13.62
17.14
1.43
-0.23
0.17
-2.97
7.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
67
76
86
94
107
120
135
178
202
227
225
Fixed Assets
24
27
33
34
39
39
44
49
55
54
50
Current Assets
42
47
49
58
67
79
89
118
133
149
148
Capital Work in Progress
0
1
1
1
0
1
0
8
12
19
23
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
43
47
52
60
69
80
92
121
136
153
152
Total Liabilities
67
76
86
94
107
120
135
178
202
227
225
Current Liabilities
50
56
63
67
71
74
77
113
138
160
140
Non Current Liabilities
11
14
7
8
10
12
11
19
18
21
15
Total Equity
6
6
16
19
26
34
47
47
46
46
70
Reserve & Surplus
-4
3
8
11
18
26
39
39
38
38
59
Share Capital
9
3
8
8
8
8
8
8
8
8
10

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
-0
1
0
-0
-1
0
0
6
Investing Activities
-3
-7
-8
-4
-5
-6
-12
-17
-16
-13
-5
Operating Activities
4
7
10
5
9
10
14
14
18
16
-5
Financing Activities
-2
-0
-2
-1
-3
-3
-2
2
-3
-3
16

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Jan 2025
Mar 2025
Jun 2025
Sept 2025
Promoter
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
74.15 %
61.09 %
61.09 %
60.99 %
59.64 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.03 %
0.06 %
0.06 %
0.05 %
0.05 %
0.02 %
0.02 %
0.02 %
0.02 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
19.04 %
18.48 %
18.27 %
18.84 %
18.91 %
19.27 %
19.29 %
19.38 %
19.40 %
19.41 %
19.60 %
19.99 %
20.00 %
20.05 %
20.13 %
18.63 %
32.22 %
23.87 %
25.35 %
25.98 %
Others
6.78 %
7.34 %
7.56 %
6.99 %
6.91 %
6.55 %
6.53 %
6.44 %
6.42 %
6.41 %
6.22 %
5.83 %
5.79 %
5.75 %
5.67 %
7.17 %
6.67 %
15.02 %
13.64 %
14.35 %
No of Share Holders
8,122
11,174
10,784
11,135
11,154
11,244
11,250
11,100
10,834
10,634
10,494
10,242
10,023
9,792
9,996
9,326
8,795
8,756
8,281
8,079

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 1 1 1.5 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 1.05 0.43 0.86 0.00 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Feb 2021 DIVIDEND Dividend
₹ 0.50 /share
17 Feb 2021 265.65 241.25
11 Sept 2021 DIVIDEND Dividend
₹ 1.00 /share
08 Sept 2021 382.00 317.95
17 Sept 2022 DIVIDEND Dividend
₹ 0.50 /share
15 Sept 2022 152.15 142.95
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 138.90 134.20
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 123.15 114.85
08 Jan 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
08 Jan 2025 211.95 289.00
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2025 262.80 264.80
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 418.70 449.75
05 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Aug 2025 340.75 320.50
27 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2025 320.50 403.60
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 386.60 387.40

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 17, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateNov 12, 2025
Announcement Under Regulation 30- Outcome Of Board Meeting Dated November 12 2025Nov 12, 2025
Results- UFR-Q2 As On 30 September 2025Nov 12, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 12, 2025
Monthly Report On Special Window For Re-Lodgement Of Transfer Request Of Physical Shares For The Month Of November 2025.Nov 10, 2025
Board Meeting Intimation for Everest Organics Ltd Has Informed BSE That The Meeting Of The Board Of Directors Of The Company Is Scheduled On 12/11/2025Inter Alia To Consider And ApproveNov 05, 2025
General Update-Monthly Report On Special Window For Re-Lodgement Of Transfer Request Of Physical Shares For The Month Of October2025.Oct 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares .Oct 03, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Proceeding Of 32Nd Annual General Meeting Of The Everest Organics Limited Held On 27Th September 2025 At 03.00 P.M Through Video Conferencing (VC).Sep 27, 2025
Closure of Trading WindowSep 20, 2025
General- Update- Monthly Report On Special Window Re-Lodgement Of Shares For The Month Of August2025.Sep 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Letter To MembersSep 05, 2025
Reg. 34 (1) Annual Report.Sep 04, 2025
32Nd Annual General Meeting -NoticeSep 04, 2025
General Updates-Newspaper PublicationAug 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Appointment of Company Secretary and Compliance OfficerAug 05, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 05, 2025
Financial Results For Quarter Ended June 30 2025.Aug 05, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On August 05 2025 For Quarter Ended June 30 2025Aug 05, 2025
Board Meeting Intimation for 1. Unaudited Financial Results Along With Limited Review Report For Quarter Ended June 30 2025 . 2. Other Business Transactions.Jul 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Issue Of Duplicate Share CertificateJul 14, 2025
Closure of Trading WindowJun 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Appointment Of AuditorsMay 28, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held From May 27 2025 To May 28 2025.May 28, 2025
Audited Financial Results For The Quarter And Financial Year Ended March 31 2025May 28, 2025
Board Meeting Intimation for Considering Inter Alia The Audited Financial Results And Statements For The Quarter And Year Ended March 31 2025May 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressApr 04, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerMar 27, 2025
Closure of Trading WindowMar 24, 2025
Receipt Of Trading Approval From BSE LimitedMar 20, 2025
Receipt Of Listing Approval From BSE LimitedMar 12, 2025
Intimation Of Korea Drug Master File (KDMF) Approval For CompanyS Rabeprazole Sodium APIFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 13, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotFeb 13, 2025
Integrated Filing (Financial)Feb 11, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held TodayFeb 11, 2025
Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024.Feb 11, 2025

Technical Indicators